# Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome

> **NCT02427334** · PHASE3 · UNKNOWN · sponsor: **Cairo University** · enrollment: 210 (estimated)

## Conditions studied

- Premenstrual Syndrome

## Interventions

- **DRUG:** Dienogest
- **DRUG:** Fluoxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02427334
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2020-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02427334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02427334, "Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02427334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*